Table 3. Patients with symptomatic cardiac events.
| Age | Sex | Time to first event (mo) | Event details | Prior cardiac morbidity | Other comorbidities | GTV (cc) | PTV (cc) | MHD (EQD2 in Gy) |
|---|---|---|---|---|---|---|---|---|
| 62 | M | 12 | ICD implantation and CHF | CAD, MI s/p CABG, tricuspid valve repair, systolic CHF | Peripheral vascular disease | 5.52 | 12.94 | 0.10 |
| 58 | M | 41 | MI s/p catheterization | MI s/p CABG, CAD | Severe COPD | 15.28 | 33.72 | 9.05 |
| 67 | M | 20 | E.D. visit for A Fib | None | H/o T2 N2 SCC LUL s/p chemoradiation to 59.6 Gy 13.5 years prior, COPD | 12.94 | 28.24 | 0.05 |
| 83 | F | 33 | E.D. visit for tachycardia | CAD s/p stent, cardiac arrhythmia | COPD, right carotid endarterectomy | 70.26 | 112.03 | 1.94 |
| 74 | F | 9 | PCI for CAD, right ventricular failure, pulmonary hypertension | CAD s/p CABG | Sarcoidosis, severe COPD | 2.04 | 7.19 | 0.09 |
| 85 | F | 6 | Hospitalized with an arrhythmia | None | COPD, peripheral vascular disease | 20.59 | 55.73 | 0.12 |
| 67 | M | 60 | Hospitalized with paroxysmal A Fib | CAD | Carotid stenosis, peripheral vascular disease | 28.14 | 71.67 | 1.49 |
| 58 | M | 23 | A Fib with RVR | None | Severe COPD, bladder carcinoma s/p cystectomy | 15.41 | 44.97 | 1.32 |
| 59 | M | 3 | NSTEMI | CAD | COPD | 15.43 | 42.69 | 3.80 |
| 61 | M | 6 | NSTEMI | A fib, pericardial disease, diastolic CHF | COPD, ESRD | 18.99 | 57.92 | 1.03 |
| 54 | M | 22 | A Flutter w/ RVR s/p cardioversion and radiofrequency ablation | Systolic CHF stage C, A Fib | COPD | 5.83 | 23.21 | 0.47 |
| 64 | M | 22 | Left ventricular systolic dysfunction | None | None | 17.79 | 49.89 | 5.69 |
| 74 | F | 17 | Diastolic CHF exacerbations, 3 NSTEMI s/p 5 stents | Moderate aortic stenosis | Severe COPD, pulmonary fibrosis, PVD, pulmonary hypertension | 5.91 | 22.05 | 2.28 |
| 66 | M | 3 | Hospitalized due to worsening CHF | A Fib, CAD s/p CABG, mitral valve replacement, CHF | Lupus, severe COPD | 4.63 | 11.9 | 1.98 |
| 58 | F | 4 | Mitral valve replacement, CHF | CHF, rheumatic mitral regurgitation s/p repair, multivessel CAD s/p CABG | h/o PE, severe COPD | 33.19 | 63.79 | 0.17 |
| 73 | F | 18 | Hospitalized due to worsening CHF | CAD, MI, CHF | COPD, CKD stage V | 65.14 | 135.88 | 7.50 |
| 72 | F | 32 | Pacemaker placement | None | COPD, asthma | 37.69 | 71.1 | 0.44 |
| 57 | F | 6 | SVT with elevated troponin due to demand ischemia with severe LVH | Diastolic heart failure, 4 cardiac stents, paroxysmal SVT | Prolonged hospital stays, intraabdominal abscesses, small bowel obstruction | 47.56 | 92.02 | 0.07 |
ICD, implantable cardioverter-defibrillator; CHF, congestive heart failure; E.D., emergency department; CAD, coronary artery disease; CABG, coronary artery bypass grafting, s/p, status post; A Fib, atrial fibrillation; h/o, history of; SCC, squamous cell carcinoma; LUL, left upper lobe; NOS, not otherwise specified; PCI, percutaneous coronary intervention; L, liters; O2, oxygen; RVR, rapid ventricular response; NSTEMI, non-ST segment elevation MI; A Flutter, atrial flutter; ESRD, end-stage renal disease; PVD, peripheral vascular disease; PE, pulmonary embolism, CKD, chronic kidney disease; SVT, supraventricular tachycardia; LVH, left ventricular hypertrophy.